Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
about
Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.
P2860
Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@en
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@nl
type
label
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@en
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@nl
prefLabel
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@en
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies.
@nl
P2093
P2860
P356
P1476
Diagnostic Value of Cerebrospi ...... and Dementia with Lewy Bodies
@en
P2093
Aurelia Gabel
Barbara Jung
Benjamin Cretin
Camille Heitz
Catherine Demuynck
Catherine Martin-Hunyadi
Frédéric Blanc
Nathalie Philippi
Sylvie Hezard
Thomas Lavaux
P2860
P304
P356
10.3233/JAD-150731
P577
2016-01-01T00:00:00Z